Faculty Profile

Hedy Kindler
Section of Hematology / Oncology
Professor of Medicine
Referring Physician Access Line: 1-877-DOM-2730
Associate Vice Chair for Clinical Research;Director, Gastrointestinal Oncology; Director, Mesothelioma Program

Academic Interests

Dr. Kindler's research focuses on new drug development for the treatment of malignant mesothelioma, advanced pancreatic cancer and other gastrointestinal malignancies. She designs and conducts clinical trials of novel agents, including angiogenesis inhibitors and other targeted drugs, for patients with these cancers. She is the chair of the Mesothelioma Subcommittee of the Cancer and Leukemia Group B, a multicenter research organization funded by the National Cancer Institute to conduct clinical trials in malignant mesothelioma and other cancers.

Clinical Interests

Pancreatic Cancer, malignant mesothelioma, colorectal cancer, gastrointestinal stromal tumors (GIST), hepatobiliary cancers.


For a complete list of publications click here:


  • BS, 1982, Yale University, Biology
  • MD, 1989, State University of New York
  • Residency, 1991, University of California Los Angeles, Internal Medicine
  • Residency, 1992, Montefiore Medical Center, Internal Medicine
  • Fellowship, 1995, Memorial Sloan-Kettering Cancer Center, Hematology/Oncology